Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates both glucose-dependent insulinotropic polypeptide receptors and GLP-1 receptors simultaneously
Once you start a GLP-1 weight-loss medication , it can feel like the hard part is overyour appetite is down, portions are smaller, and the scale finally moves
Scientists are also looking at how these peptides might help protect the skin from oxidative damage and support overall skin health
In a meeting
Endocr Pract 26(1):107139 Boye K, Ross M, Mody R, Konig M, Gelhorn H (2021) Patients preferences for once-daily oral versus once-weekly injectable diabetes medications: the REVISE study
This unique mechanism has shown remarkable potential in early human trials for tackling obesity, T2D, and related conditions like non-alcoholic fatty liver disease (NAFLD)